Results 81 to 90 of about 141,167 (306)
Paraneoplastic thrombocytosis in ovarian cancer [PDF]
<p>Background: The mechanisms of paraneoplastic thrombocytosis in ovarian cancer and the role that platelets play in abetting cancer growth are unclear.</p> <p>Methods: We analyzed clinical data on 619 patients with epithelial ...
Han, H.D. +33 more
core +1 more source
DJ-1 is a reliable serum biomarker for discriminating high-risk endometrial cancer
New reliable approaches to stratify patients with endometrial cancer into risk categories are highly needed. We have recently demonstrated that DJ-1 is overexpressed in endometrial cancer, showing significantly higher levels both in serum and tissue of ...
Annalisa Di Cello +10 more
doaj +1 more source
This study identifies SNRPF as a critical oncogenic driver in ovarian cancer. By regulating a self‐sustaining SNRPF–DDX24–E2F4 feedback loop through intron retention and nonsense‐mediated decay, SNRPF couples RNA splicing with transcriptional regulation to promote tumor progression.
Yingwei Li +4 more
wiley +1 more source
Glycemic index, glycemic load and endometrial cancer risk: results from the Australian National Endometrial Cancer study and an updated systematic review and meta-analysis [PDF]
The relationship between habitual consumption of foods with a high glycemic index (GI) and/or a diet with a high glycemic load (GL) and risk of endometrial cancer is uncertain, and relatively few studies have investigated these associations.
Webb, Penelope M. +13 more
core +1 more source
Identify effect of SERPINA3 up-regulated expression in endometrial cancer
Background and purpose: SERPINA3 is a protease inhibitor, belonging to the serpin super family. It has been reported that SERPINA3 expression up-regulated in various tumor cells.
杨广东, 任渊, 张蓉
doaj
This study addresses the rapid renal clearance of anti‐HER2 nanobodies by developing specialized liposomal carriers. It details the formulation of dual modified liposomes, demonstrating how PEGylation preserves structural integrity and cell‐penetrating peptides enhance cellular interaction.
Giulia Pander +14 more
wiley +1 more source
Parity Correlates with the Timing of Developing Endometrial Cancer, But Not Subtype of Endometrial Cancer. [PDF]
Parity is one of well-known risk factors of endometrial cancer, but it is less clear whether parity is associated with the timing of developing endometrial cancer, and with the incidence of subtype of endometrial cancer.
Tong, Mancy +4 more
core +1 more source
PhosSight is a unified deep‐learning framework for phosphoproteome identification, featured by a phosphorylation‐aware detectability predictor. It improves identification sensitivity in DDA through deep re‐localization and rescoring, accelerates DIA searches by detectability‐guided spectral library pruning, and expands phosphoproteome coverage to ...
Ben Wang +10 more
wiley +1 more source
Caracterització del factor de transcripció ERM/ETV5 durant la infiltració miometrial i aproximacions proteòmiques al procés d'invasió en càncer d'endometri [PDF]
[cat] El càncer d'endometri és la malaltia ginecològica més comuna i representa la quarta neoplàsia més freqüent en la dona en els països desenvolupats.
Monge i Azemar, Marta
core
Telomeres and telomerase in endometrial cancer and hyperplasia [PDF]
Introduction The study aimed to measure telomeres length (TL) and telomerase expression in normal endometrium and endometrial hyperplasia and cancer. Material and methods Total RNA and DNA were isolated from endometrium samples of 117 patients.
Anna Pańczyszyn +4 more
core +1 more source

